FCF Yield

Eli Lilly’s free cash flow yield of 0.6% means the company generates only 0.6 cents in free cash for every dollar of its current stock price — a low return compared to the Healthcare sector median of 3.4%.

The stock sits in the 18th percentile among sector peers, indicating most competitors offer a higher cash return per share price. Trend data is unavailable because the year-over-year and quarter-over-quarter changes are both labeled N/A, and no historical values beyond the current 0.6% are provided for the last eight quarters. The combination of a very low yield with no trend information leaves both the risk and opportunity unclear — investors cannot assess whether cash generation is improving or deteriorating. This metric does not contradict the overall NEUTRAL verdict, as the deficient yield alone is not enough to tilt the stock negative, but it also offers no positive signal to support an upgrade.

Frequently Asked Questions

Closest Sector Peers